Revvity, Inc. (NYSE: RVTY ) offers instruments, reagents and assays in the life sciences and diagnostics markets, with recurring business representing around 80% of total revenues. I favor the company’s focus on key growth markets including cell and geneAnalyst’s Disclosure:I/we have a beneficial long position in the shares of RVTY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than f ...